Market Regulation

DEVELOPMENTS
Eli Lilly’s Weight Loss Pill Gains U.S. Approval
Eli Lilly’s Weight Loss Pill Gains U.S. Approval

FDA approval followed late-stage trials involving thousands of participants. Those taking orforglipron lost significantly more weight than participants who received a placebo.








LATEST IN FINANCIAL LITERACY

Content provided by finlittoday.com

No posts available at this time.